This content is provided as general scientific reference material and does not establish product-specific testing results or specifications.
Purity testing and identity testing address related but distinct analytical questions. A purity test evaluates the relative composition detected under a specified analytical method, while an identity test determines whether the measured characteristics align with the material specified in the report.
Since these two concepts are not interchangeable, researchers should clearly identify which test was conducted and should not consider a single purity percentage as definitive proof of material identity, quantity, or sterility.
What Purity Testing Evaluates
Chromatographic purity testing may report the relative detector response associated with the principal or identified component under defined analytical conditions. Chromatographic methods such as HPLC can separate detectable components under the conditions of the method and produce corresponding detector signals.
In area-normalization approaches, chromatographic purity may be calculated from the relative integrated peak areas detected under the method. The meaning of the value depends on the method, detector response, integration rules, sample preparation, and components that the procedure can detect.
For that reason, chromatographic purity should not automatically be interpreted as the percentage by weight of the target material in the vial. It also does not independently establish molecular identity or the absence of every possible impurity.
What Identity Testing Evaluates
Identity testing evaluates whether measured characteristics correspond with those expected for the specified material. In regulated drug-development contexts, FDA and ICH analytical guidance treats identification, impurity testing, and quantitative assay procedures as distinct analytical purposes.
For peptide research, mass spectrometry may be used to compare an observed mass with an expected molecular mass. Tandem mass spectrometry may provide fragment-ion information that offers additional evidence relevant to a proposed identification.
A mass match is one piece of evidence. The strength of an identity conclusion depends on the procedure, charge-state assignment, mass accuracy, reference information, fragment data when available, and the laboratory’s stated acceptance criteria.
Material Amount Is a Separate Question
Neither chromatographic purity nor a molecular-mass match automatically establishes how much target material is present in a submitted vial. A quantitative assay determines or estimates a defined amount, concentration, or content using a specified analytical procedure and appropriate reference information.
A sample may show a high relative chromatographic purity result while the measured material amount differs from the labeled amount. Conversely, an amount result does not by itself establish that every detected component has been identified.
How the Tests Complement One Another
When purity, identity, and quantitative methods are all reported, they can provide complementary information:
• Purity testing can describe the relative chromatographic composition observed under the method
• Identity testing can compare measured molecular characteristics with those expected for the specified material
• Quantitative testing can determine or estimate a defined amount, concentration, or content using the stated method
• Microbial or other specialized tests can address separate characteristics not measured by the chemical analyses
The presence of one result should not imply that the other analyses were performed.
Review the Method and Reported Basis
Before interpreting a purity or identity statement, researchers can ask:
• What analytical method is named in the report?
• Is the result chromatographic purity, assay content, molecular mass, or another measurement?
• Does the report state how the percentage or value was calculated?
• Where applicable, are the expected value, specification, or acceptance criteria shown?
• Was the result produced for the correct product and batch?
• Does the report include chromatograms, spectra, or supporting data?
• Are any components, methods, or limitations left unspecified?
Special Considerations for Blended Materials
A blended material may require separate evaluation of its components. A single chromatographic purity value, combined mass result, or total material amount may not establish the identity and quantity of every component in the blend.
Researchers should determine whether the report lists each component separately, whether the method can distinguish the components, and whether the reported result applies to the entire blend or to individual analytes.
Interpret Results Within Their Scope
Purity and identity results are most useful when they are connected to the applicable sample, method, batch, specification, and supporting data. The full available report should be evaluated rather than relying on a product-page summary or a single headline percentage.
View the Grey Axis COA Library
Research Use Only
Grey Axis Research products are intended for in-vitro laboratory research and analytical purposes only. Human or animal use, including clinical, medical, diagnostic, therapeutic, or cosmetic applications, is strictly prohibited.